Research & Development: Page 71

PharmaVoice Team/PharmaVoice

Shifting the Long-term Care Dynamic

Managed MARKETS Big payer changes have been taking place in the long-term care arena as a result of the introduction of Medicare Part D. Before 2006, the pri marypayers in longtermcarewere the state Med icaid plans. Now, multiple payers are covering patients, and insurance companies in particular...
By Denise Myshko • May 28, 2008
PharmaVoice Team/PharmaVoice

Matt Emmens — Driving Success

In the engine room of a company, leaders and internal experts conceptualize and form direction. The decisions they make determine a company’s success rate. It’s in this capacity that Matt Emmens takes a lead. He knows how to diagnose what’s wrong with the engine and how to get all the components ...
By Kim Ribbink • May 27, 2008
Explore the Trendline➔

Stock via Getty Images

Trendline

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff
PharmaVoice Team/PharmaVoice

A Growing Community of Good Citizens, Part II

SPECIAL FEATURE # CITIZENS PHILANTHROPY HAS BECOME PART AND PARCEL OF CORPORATE LIFE IN MANY NATIONS.FOR SOME COMPANIES IN THE LIFESCIENCES, HOWEVER,THERE IS A GROWING DESIRE TO TAKE THAT ONE STEP FURTHERWITH GRASSROOTSVOLUNTEERISM. Last month, PharmaVOICE told its readers about some of the remar...
By Kim Ribbink • May 27, 2008
PharmaVoice Team/PharmaVoice

Last Word

Michelle GadsdenWilliams is VP and Global Head of Diversity and Inclusion at Novartis Pharma AG.She was one of 75 women honored for her accomplishments at the 2005 Tribute to Women in Industry (TWIN) Gala, Harvard’s 2008 BMF Businesswoman of the Year, the Rainbow Push Coalition’s Bridge Builder A...
By PharmaVoice Team • May 27, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

As patients live longer and are increasingly diagnosed with chronic and often debilitating ailments, pharmaceutical decisionmakers find themselves examining ways to adapt their organizations to address the resulting healthcare needs in both human and business terms. According to the report, the p...
By PharmaVoice Team • May 27, 2008
PharmaVoice Team/PharmaVoice

17th Annual Partnerships with CROs

17th Annual Partnerships with CROs Hundreds of clinical development and outsourcing professionals gathered in Las Vegas for the annual conference. Attendees were treated to a packed lineup of workshops, tracks, and keynote addresses covering the hot topics in clinical research and development. .E...
By PharmaVoice Team • April 30, 2008
PharmaVoice Team/PharmaVoice

Dr. Bob Sliskovic — A Quest for Discovery

keeps scientists like Dr. Sliskovic in search of the next great compound. “The anticipation of success is an extreme ly powerful stimulant,” he says. “I’ve watched scientists receive the cruelest blows in terms of having a pet compound die, but the next morning they would be back and raring to go...
By Kim Ribbink • April 30, 2008
PharmaVoice Team/PharmaVoice

On the Calendar

ONTHE CALENDAR May 1516 13th Annual Pharmaceutical &Biotech Licensing &Deal Making Summit Hyatt Regency NewBrunswick,New Brunswick,N.J. For more information, contact Cheryl KahanRadhuber,Strategic Research Institute, at 2129670095, email [email protected], or visit srinstitut...
By PharmaVoice Team • April 29, 2008
PharmaVoice Team/PharmaVoice

E-Media

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES eDrugSearch has unveiled the eDrugSearch.com Community, a social network for Americans seeking safe, lowcost prescrip tion medications online. The Health 2.0 community comple ments eDrugSearch’s specialized search engine for prescr...
By PharmaVoice Team • April 29, 2008
PharmaVoice Team/PharmaVoice

What's New

NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Immune Tolerance Institute (ITI), a new nonprofit company, is bringing economies of scale to translational and critical path science to build partnerships with the pharmaceutical and biotech industries, and accelerate the development of new ...
By PharmaVoice Team • April 29, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

Expansion in size and number of clinical trials. The increase in clinical trials has been prompted by regulators seeking more extensive study data to validate drug safety. Greater numbers of postmarketing Phase IV studies and a rising level of drug development activity have also contributed to th...
By PharmaVoice Team • April 29, 2008
PharmaVoice Team/PharmaVoice

The Fourth Hurdle: The Call for Pharmacoeconomic Data

Managed MARKETS What began as a movement by government payers in other parts of the world is now making its mark here in the United States. Pharmacoeconomics — the scientific discipline that compares the value of one pharmaceutical drug to another to assess its value and costeffectiveness — has b...
By Denise Myshko • April 29, 2008
PharmaVoice Team/PharmaVoice

PharmaOutlet

Study Coordinator A is an early adopter of technology on the cutting edge of the next generation processes who is always eager to try something new. Study Coordinator B is a risk averse, technological laggard who subscribes to the “if it isn’t broken, don’t fix it” mantra. Herein lies one of the ...
By Gil Kampfer • April 29, 2008
PharmaVoice Team/PharmaVoice

UpFront

SOURCE:CEGEDIMDENDRITE,BEDMINSTER,N.J. DTC ALERT Shift to Physician Offices, Online Programs Cegedim Dendrite’s annual survey indicates DTC marketing is moving away from traditional mass media promotion. According to the survey, almost twothirds of marketers want to see more spending on emerging ...
By PharmaVoice Team • April 29, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

Every month our goal is to feature thought leaders who have the ability to change the course of the industry. This month we exceeded this goal in spades. We are pleased to pay homage to the HBA’s 95 Rising Stars, some of the industry’s brightest and most talented individuals. These executive wome...
By Taren Grom • April 29, 2008
PharmaVoice Team/PharmaVoice

From Scorpion to Cancer

MOTHER NATURE BUILT IT, MAN IS IMPROVING IT. TransMolecular’s 131 ITM601 is a synthetic version of a peptide from the venom of scorpions combined with a radioactive iodine. In Phase I/II trials to treat glioma,a deadly form of brain cancer, the product can deliver a targeted dose of radiation to ...
By Denise Myshko • April 25, 2008
PharmaVoice Team/PharmaVoice

E-Media

84 F e b ru a r y 200 3 PharmaVOICE EMEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ProscapeTechnologies has anew Internet tool to make facetoface selling more effective. Proscape.Net provides mobile sales organizations a common technolo gy platform to exchange, update, c...
By PharmaVoice Team • April 24, 2008
PharmaVoice Team/PharmaVoice

What's New

WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Pharmaceutical companies wanting to gain an edge in managedcare markets can turn to PharmaStrat Inc. for comprehensive market research services.The recently launched company was founded by Philip J. Patrick, a pharmaceutical execu...
By PharmaVoice Team • April 24, 2008
PharmaVoice Team/PharmaVoice

On the Calendar

February 10,2003,Park Hyatt San Francisco — San Francisco European Regulatory Affairs: An InDepth Review of Registration Procedures in the European Union This Drug Information Association training course will cover the evolu tion of the registration systems available for approval of products sinc...
By PharmaVoice Team • April 24, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

Survey Shows One Third of Americans USE ANTIBIOTICS INAPPROPRIATELY A survey conducted by Harris Interactive has revealed that one out of three Americans mistakenly believes antibiotics are effective in treating viruses such as cold and flu and takes these drugs to fight these viruses. The survey...
By PharmaVoice Team • April 24, 2008
PharmaVoice Team/PharmaVoice

PharmaOutlet

When launching a newproduct, marketers tend to focus on core audiences such as the physician and the patient, and on the clinical aspects of the drug, highlighting safety and clinical effectiveness. These factors are essential to a successful launch, but there are two additional fac tors that are...
By PharmaVoice Team • April 24, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski MANAGING EDITOR Denise Myshko CONTRIBUTING EDITORS Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Three, ...
By PharmaVoice Team • April 24, 2008
PharmaVoice Team/PharmaVoice

Walt Woltosz — Quantum Leap

Walt Woltosz is using his experience with simulation software in the aerospace industry to try to transform the way pharmaceutical companies approach data gathering and research, and he’s proving that it just might take a rocket scientist to get the industry on track. WHAT DOES THE PHARMACEUTICAL...
By Kim Ribbink • April 24, 2008
PharmaVoice Team/PharmaVoice

Crossing the EDC Chasm

By Dr. Paul Bleicher The emergence of comprehensive eCDM solutions that can seamlessly link together traditional and electronic data management may be the technology that sponsors are still seeking. IN AN EXCLUSIVE INTERVIEW WITH PHARMAVOICE, PAUL BLEICHER, M.D., PH.D., FOUNDER, CHAIRMAN, AND CHI...
By PharmaVoice Team • April 24, 2008
PharmaVoice Team/PharmaVoice

E-Media

NEW ELECTRONIC AND WEB-BASED APPLICATIONS, SITES, AND TECHNOLOGIES CLINPHONE Unveils New Website ClinPhone has redesigned its Website, clinphone.com, to give it more functionality and a portal style. The site contains more product information than the previous site, including details of ClinPhone...
By PharmaVoice Team • April 22, 2008